Therapeutics - approach to treatment Flashcards

1
Q

Why administer drugs?

A

Cure underlying disease Prevent or slow progression of disease Increase life expectancy Improve quality if not length of life

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Outline steps to appropriate management - 4

A

Correct ID of underlying disease Stage severity Apply EBVM In absence of ‘best evidence’, make an informed and rational decision

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Define EBVM

A

the conscientious, explicit, and judicious use of current best evidence in making decisions about the care of individual patients

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is the best evidence?

A

Well-designed, blinded, prospective studies. The next-best evidence comes from lower quality sources such as case-control studies, retrospective uncontrolled studies, case series, individual case reports and expert opinion.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the best evidenced tx for MVD (dogs)?

A

Pimobendan ACEI Spironolactone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Best evidenced Tx for DCM

A

Pimobendan and ACEI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Best evidenced Tx for feline HCM

A

ACEI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

How can CSs of cardiac disease be divided up in terms of thinking about therapy?

A

Is the patient showing congestive signs (wet) or outpt signs (i.e. ‘cold’) or both?

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Define lusitropy

A

the ability of the heart to relax

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are the different signs that could underlie the the signs present in a patient?

A

Increased preload Increased afterload Impaired inotropy Impaired lusitropy Abnormalities of cardiac rate and rhythm

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Main sign of excessive preload

A

Congestion - detectable on PE or radiographs. Oedema, ascites, peripheral oedema, pleural oedema, pleural effusion and venous congestion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Tx - preload reduction

A

DIURETICS AND VENODILATORS

Providing the underlying disease is readily rectifiable, diuresis with or without venodilation will be required.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

When to treat for afterload reduction? How?

A

Patients are likely to appear pale or cold. Treatment for this will help when the patient has mitral regurgitation. HOW: arteriodilators (if no fixed obstruction)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

When might you want to improve systolic function?

A

DCM and later stages of MVD. Use inotropic agents may improve output and signs.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

When might diastolic function need to be improved? What drugs should be used?

A

when the heart muscle is excessively hypertrophied or where there is excessive fibrosis. DRUGS TO USE: hasten relaxation (calcium channel blockers), slow HR (beta-blockers) or reduce fibrosis (ACEI).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

How can you optimise heart rate and rhythm?

A

Changing SV and HR and therefore CO.

17
Q

List classes of diuretic

A
  • DIURETICS - Frusemide and Torasemide - THIAZIDES - chlorothiazide, hydrochlorothiazide - POTASSIUM SPARING DIURETICS: spironolactone, amiloride
18
Q

How can diuretics be used initially and when they become refractory to this?

A
  • USUALLY START DIURESIS WITH A SINGLE AGENT: fursemide at 1-2mg/kg orally 2-3 times, administer at higher doses and IV where animal is in more severe HF. WHEN PATIENT BECOMES REFRACTORY TO FRUSEMIDE: can increase dose, increase freqency, introduce second diuretic - sequential blockade (spironolactone), swap to torasemide
19
Q

Risks of diuresis

A

Hypovolaemia Hypotension Electrolyte disturbances Stimulation of RAAS

20
Q

Outline venodilation

A

VENODILATORS - glyceryl trinitrate - percutaneously administered ointment or cutaneous patches BALANCED VASODILATORS - act on arteries and veins - ACEI, pimobendan and nitroprusside

21
Q

Define afterload

A

the peak ventricular wall tension during systole

22
Q

What are the benefits of afterload reduction?

A

Increased SV Increased CO Decreased MR Reduced systolic wall tension reduces cardiac work - decreased myocardial oxygen demand, improved oxygenation of the myocardium

23
Q

Risks of afterload reduction

A

Hypotension Reduction in SVR may result Decreased BP may compromise perfusion of essential vascular beds

24
Q

List agents for afterload reduction

A

BALANCED VASODILATORS: ACEI, pimobendan, others (calcium channel blockers - amlodipine, xanthnes, alpha-blocers), ARTERIODILATORS - hydralazine

25
What are problems with inotropes?
INCREASED MYOCARDIAL WORK - may be associated with increased rate of myocardial deterioration, increased mortality in humans INCREASED MYOCARDIAL OXYGEN DEMAND - exacerbate ischaemia/hypoxia, may lead to rhythm disturbances DIGOXIN EXCEPTION DUE TO OTHER EFFECTS: reduced HR, decreased SNS tone.
26
What is pimobendan evidence for?
Good evidence of efficacy in DCM after the onset of HF
27
What are indications for other inotropes?
SYSTOLIC FAILURE SHORT TERM REQUIRED AS EMERGENCY MEASURE - dobutamine infusion DIGOXIN: HF associated with systolic failure of myocardium, supraventricular rhythm disturbance
28
What broad categories of drugs can you use to improve output signs? 3
Inotropes Afterload reduction Anti-arrhythmics
29
How can you improve congestive signs? 2
Diuretics/venodilators Preload reduction
30
Outline the use of anti-arrhythmic agents
Controversial and fairly hazardous area No licensed agents Always do with caution
31
What are overall aims of therapy - 4
- Restore adequate peripheral perfusion - Control rate and frequency of rhythm - Restore sinus rhythm - not always possible or necessary - Prevention of sudden death
32
How can cardiac rate and rhythm be optimised? 3
ANTI-DYSRHYTHMIC MEDICATION: - ventricular arrhythmias (lignocaine, procainamide, beta-blockers) - supraventricular arrhythmias (digoxin, calcium channel blockers, beta-blockers) - Bradyarrhythmias (atropine, propantheline bromide, xanthines, pacing)
33
What should you do if you diagnose AF?
See diagram
34
Broad treatment option for afterload reduction
Arteriodilators OR balanced vasodilators
35
Main Tx to enhance systolic function
Inotropes
36
Main Tx to enhance diastolic function
Lusitropes OR negative chronotropes
37
Main Tx to optimise cardiac rate and rhythm
Anti-arrhythmics (not licensed and potentially hazardous. Use all with care and only when you are certain they are indicated)
38
When are anti-thrombotics principally used?
In cats at risk of aortic thromboembolism - aspirin adn clopidogrel